期刊文献+

慢性丙型肝炎患者肝组织学改变及其影响因素分析 被引量:3

Liver histological changes and influencing factors in patients with chronic hepatitis C
原文传递
导出
摘要 目的探讨慢性丙型肝炎患者肝组织学改变及其影响因素。方法选择经皮肝组织活检的慢性丙型肝炎患者102例,记录患者年龄、性别、体质指数(BMI)、感染途径等,检测ALT水平、AST水平、HCV基因分型、病毒载量和肝脏组织学改变。统计学处理采用t检验和Logistic回归分析。结果肝脏炎症活动指数(HAD≥4的慢性丙型肝炎患者的ALT、AST水平较高,PLT较低,与HAI〈4的患者相比差异有统计学意义(t=2.209、2.298、2.565,均P〈0.05)。纤维化分期评分(F)≥3的患者平均年龄、ALT水平、AST水平以及感染时间均高于F〈3的患者(t=2.340、3.497、2.758、2.570,均P〈0.05),而PLT则较低(t=2.761,P=0.007)。女性、ALT〉1×正常值上限(ULN)、AST水平、F≥3、HCVRNA≥6 lgIU/mL和PLT计数是HAI≥4的单因素预测因子;经多因素分析后,Ishak纤维化分期评分是HAI≥4的唯一独立预测因子(OR3.098,95%CI 1.884~5.092,P〈0.01)。单因素分析F≥3的预测因子为年龄、BMI≥24kg/m^2、ALT〉1×ULN、AST水平、HAI≥4、PLT计数以及感染年限≥15年;多因素回归分析显示,年龄(OR 1.074,95%CI 1.006~1.146,P=0.033)、ALT水平(OR1.035,95%CI 1.015~1.055,P〈0.01)、AST水平(OR0.969,95%CI 0.948-0.990,P=0.005)、感染年限≥15年(OR37.215,95%CI 5.816~238.1.27,P〈0.01)和HAI≥4(OR 1.939,95%C1 1.426~2.636,P〈0.01)是F≥3的独立危险因素。结论年龄、ALT水平、AST水平、感染年限≥15年和HAI≥4是肝组织学显著纤维化的独立预测因子。 Objective To investigate the histological features as well as the factors influencing liver disease progression in Chinese patients with chronic hepatitis C (CHC). Methods A total of 102 CHC patients who underwent percutaneous liver biopsy between August 2007 and May 2010 were recruited. Age, gender, body mass index (BMI) and transmission route of recruited patients were recorded. Serum levels of alanine transaminase (ALT) and aspartate transaminase (AST), HCV genotypes, HCV viral load and liver histological changes were detected. Statistical analysis was done by t test and Logistic regression. Results The serum levels of ALT and AST in CHC patients with histological activity index (HAD≥4 were much higher, while piatelet (PLT) counts were lower than those with HAI 〈4(t=2. 209, 2. 298 and 2. 565, respectively; all P〈0.05). Likewise, in patients with F≥3, the serum levels of ALT and AST as well as the mean age and the duration of infection were significantly elevated compared with F 〈 3 group (t = 3. 497, 2. 758, 2. 340 and 2. 570, respectively; all P〈0. 05), while PLT counts were much lower (t = 2. 761, P= 0. 007). The unvariate predictors for HAI≥4 were female, ALT2〉1× upper limits of normal (ULN), AST level, F≥3, HCV RNA≥6 lgIU/mL and PLT counts. By mutivariate analysis, the Ishak stage score was the only independent predictor for HAI≥4 (OR 3. 098, 95%CI 1. 884-5.092; P〈0.01). Finally, the univariate predictors for F≥3 were age, BMI≥24 kg/m2, ALT〉1×ULN, AST level, HAI≥4, PLT counts and duration of infection≥15 years. Multivariate analysis revealed that age (OR 1. 074, 95%CI 1. 006-1. 146; P=0. 033), ALT level (OR 1. 035, 95%CI 1. 015-1. 055% P〈0.01), AST level (OR 0.969, 95%CI 0. 948-0. 990; P=0. 005), the duration of infection≥15 years (OR 37. 215, 95% CI 5. 816-238. 127; P〈0.01) and HAI≥4 (OR 1. 939, 95% CI 1. 426-2. 636; P% 0.01) were independent predictors for F≥3. Conclusion Age, ALT level, AST level, duration of infection≥15 years, HAI≥4 are independent predictors for liver fibrosis.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2011年第9期534-539,共6页 Chinese Journal of Infectious Diseases
基金 国家科技重大专项(2008ZX10002-014) 上海市科委基础研究重点项目(08JC1415300)
关键词 肝炎 丙型 慢性 肝硬化 丙氨酸转氨酶 天冬氨酸氨基转移酶类 年龄因素 活组织检查 Hepatitis C, chronic Liver cirrhosis Alanine transaminase Aspartate aminotransferases Age factors Biopsy
  • 相关文献

参考文献2

二级参考文献36

  • 1[1]NIH Consensus Statement on Management of Hepatitis C:2002.NIH Consens State Sci Statements 2002; 19:1-46
  • 2[2]Simmonds P,Bukh J,Combet C,Deleage G,Enomoto N,Feinstone S,Halfon P,Inchauspe G,Kuiken C,Maertens G,Mizokami M,Murphy DG,Okamoto H,Pawlotsky JM,Penin F,Sablon E,Shin-I T,Stuyver LJ,Thiel HJ,Viazov S,Weiner AJ,Widell A.Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes.Hepatology 2005;42:962-973
  • 3[3]Penin F,Dubuisson J,Rey FA,Moradpour D,Pawlotsky JM.Structural biology of hepatitis C virus.Hepatology 2004; 39:5-19
  • 4[4]Pawlotsky JM.Use and interpretation of virological tests for hepatitis C.Hepatology 2002; 36:S65-S73
  • 5[5]Colin C,Lanoir D,Touzet S,Meyaud-Kraemer L,Bailly F,Trepo C.Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays:an analysis of the literature.J Viral Hepat 2001; 8:87-95
  • 6[6]Pawlotsky JM,Lonjon I,Hezode C,Raynard B,Darthuy F,Remire J,Soussy CJ,Dhumeaux D.What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology 1998; 27:1700-1702
  • 7[7]Pawlotsky JM,Prescott L,Simmonds P,Pellet C,Laurent-Puig P,Labonne C,Darthuy F,Remire J,Duval J,Buffet C,Etienne JP,Dhumeaux D,Dussaix E.Serological determination of hepatitis C virus genotype:comparison with a standardized genotyping assay.J Clin Microbiol 1997; 35:1734-1739
  • 8[8]Pawlotsky JM.Molecular diagnosis of viral hepatitis.Gastroenterology 2002; 122:1554-1568
  • 9[9]Martell M,Gomez J,Esteban JI,Sauleda S,Quer J,Cabot B,Esteban R,Guardia J.High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA.J Clin Microbiol 1999; 37:327-332
  • 10[10]Komurian-Pradel F,Paranhos-Baccala G,Sodoyer M,Chevallier P,Mandrand B,Lotteau V,Andre P.Quantitation of HCV RNA using real-time PCR and fluorimetry.J Virol Methods 2001; 95:111-119

共引文献62

同被引文献43

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部